223 related articles for article (PubMed ID: 23728936)
21. Prevalence of 25(OH) vitamin D insufficiency and deficiency in pediatric patients on chronic dialysis.
Cho HY; Hyun HS; Kang HG; Ha IS; Cheong HI
Perit Dial Int; 2013; 33(4):398-404. PubMed ID: 23209039
[TBL] [Abstract][Full Text] [Related]
22. Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome.
Aggarwal A; Yadav AK; Ramachandran R; Kumar V; Kumar V; Sachdeva N; Khandelwal N; Jha V
Nephrology (Carlton); 2016 Jun; 21(6):483-9. PubMed ID: 26428957
[TBL] [Abstract][Full Text] [Related]
23. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
[TBL] [Abstract][Full Text] [Related]
24. Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D.
Sollid ST; Hutchinson MY; Berg V; Fuskevåg OM; Figenschau Y; Thorsby PM; Jorde R
Eur J Endocrinol; 2016 Apr; 174(4):445-52. PubMed ID: 26733479
[TBL] [Abstract][Full Text] [Related]
25. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast Growth Factor 23 as Regulator of Vitamin D Metabolism.
Nakatani S; Nakatani A; Mori K; Emoto M; Inaba M; Razzaque MS
Adv Exp Med Biol; 2022; 1362():47-54. PubMed ID: 35288872
[TBL] [Abstract][Full Text] [Related]
27. Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes.
Leaf DE; Waikar SS; Wolf M; Cremers S; Bhan I; Stern L
Clin Endocrinol (Oxf); 2013 Oct; 79(4):491-8. PubMed ID: 23414198
[TBL] [Abstract][Full Text] [Related]
28. Differences in 25-Hydroxyvitamin D Clearance by eGFR and Race: A Pharmacokinetic Study.
Hsu S; Zelnick LR; Lin YS; Best CM; Kestenbaum B; Thummel KE; Rose LM; Hoofnagle AN; de Boer IH
J Am Soc Nephrol; 2021 Jan; 32(1):188-198. PubMed ID: 33115916
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort.
Kumar J; McDermott K; Abraham AG; Friedman LA; Johnson VL; Kaskel FJ; Furth SL; Warady BA; Portale AA; Melamed ML
Pediatr Nephrol; 2016 Jan; 31(1):121-9. PubMed ID: 26307635
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of anemia and serum iPTH, calcium, and phosphorus in patients with primary glomerulonephritis.
Li Y; Zhang W; Ren H; Wang W; Shi H; Li X; Chen X; Shen P; Wu X; Xie J; Chen N
Contrib Nephrol; 2013; 181():31-40. PubMed ID: 23689565
[TBL] [Abstract][Full Text] [Related]
31. Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease.
Kendrick J; Cheung AK; Kaufman JS; Greene T; Roberts WL; Smits G; Chonchol M;
Am J Kidney Dis; 2012 Oct; 60(4):567-75. PubMed ID: 22621970
[TBL] [Abstract][Full Text] [Related]
32. The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.
Taal MW; Thurston V; McIntyre NJ; Fluck RJ; McIntyre CW
Kidney Int; 2014 Aug; 86(2):407-13. PubMed ID: 24429404
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Two ELISA Methods and Mass Spectrometry for Measurement of Vitamin D-Binding Protein: Implications for the Assessment of Bioavailable Vitamin D Concentrations Across Genotypes.
Denburg MR; Hoofnagle AN; Sayed S; Gupta J; de Boer IH; Appel LJ; Durazo-Arvizu R; Whitehead K; Feldman HI; Leonard MB;
J Bone Miner Res; 2016 Jun; 31(6):1128-36. PubMed ID: 27250744
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
Koizumi M; Komaba H; Fukagawa M
Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
[TBL] [Abstract][Full Text] [Related]
35. Why should we measure free 25(OH) vitamin D?
Tsuprykov O; Chen X; Hocher CF; Skoblo R; Lianghong Yin ; Hocher B
J Steroid Biochem Mol Biol; 2018 Jun; 180():87-104. PubMed ID: 29217467
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship.
Powe CE; Ricciardi C; Berg AH; Erdenesanaa D; Collerone G; Ankers E; Wenger J; Karumanchi SA; Thadhani R; Bhan I
J Bone Miner Res; 2011 Jul; 26(7):1609-16. PubMed ID: 21416506
[TBL] [Abstract][Full Text] [Related]
37. Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.
Strugnell SA; Sprague SM; Ashfaq A; Petkovich M; Bishop CW
Am J Nephrol; 2019; 49(4):284-293. PubMed ID: 30878999
[TBL] [Abstract][Full Text] [Related]
38. Measured free 25-hydroxyvitamin D in healthy children and relationship to total 25-hydroxyvitamin D, calculated free 25-hydroxyvitamin D and vitamin D binding protein.
Lopez-Molina M; Santillan C; Murillo M; Valls A; Bosch L; Bel J; Granada ML
Clin Biochem; 2018 Nov; 61():23-27. PubMed ID: 30130523
[TBL] [Abstract][Full Text] [Related]
39. Role of change in vitamin D metabolism with age in calcium and phosphorus metabolism in normal human subjects.
Fujisawa Y; Kida K; Matsuda H
J Clin Endocrinol Metab; 1984 Oct; 59(4):719-26. PubMed ID: 6541227
[TBL] [Abstract][Full Text] [Related]
40. Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients.
Bhan I; Powe CE; Berg AH; Ankers E; Wenger JB; Karumanchi SA; Thadhani RI
Kidney Int; 2012 Jul; 82(1):84-9. PubMed ID: 22398410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
